Search

Givaudan is proud to announce the opening of its new White Biotechnology Innovation Centre (BIC) in Toulouse.

In the first nine months of 2025 Givaudan recorded sales of CHF 5,743 million, an increase of 5.7% on a like-for-like¹ (LFL) basis and an increase of 1.7% in Swiss francs.

Givaudan announced the groundbreaking of its new, state-of-the-art liquids production facility in Reading, Ohio, reinforcing its continued commitment to the North American region.